Eiko Lifesciences Ltd 540204.BO

₹49.89 ₹1.51 (2.94%) 1D

Last Updated: May 15, 12:00 AM·BSE

540204.BO Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: January 27, 2026

Report Source: 2026 2nd Quarter Report

Eiko Lifesciences Ltd

Eiko Lifesciences Ltd. Stock Analysis 540204.BO

India N/A Nano Cap Report:
Eiko LifeSciences Ltd. engages in the business of manufacturing, processing, formulating, producing, buying, selling and exporting Speciality and Fine Chemicals. The company is headquartered in New Delhi, Delhi and currently employs 7 full-time employees. The company went IPO on 2016-12-13. The company operates in the Specialty & Fine Chemicals segment. The company offers products in Specialty Chemicals and Intermediates, Application Programming Interfaces (APIs), Agrochemical Intermediates, Flavor & Fragrances, and Cosmetic Emollients. Specialty Chemicals and Intermediates include Lasamide, Trichloro Salicylic acid, Chloroacetyl Xylidide and Thiodipropionic acid. Agrochemical Intermediates include 5-chloro-8-hydroxyquinoline. Cosmetic Emollients include Isopropyl Oleate, Isopropyl Laurate, Isopropyl Palmitate, Isopropyl Myristate, Methyl Myristate, Butyl Oleate, Butyl Laurate, and Methyl Myristate, among others. APIs include Topiramate Indian Pharmacopoeia (IP), (United States Pharmacopeia) USP/ European Pharmacopeia (EP), and Glucosamine hydrochloride (HCL)/Sodium/Potassium USP/EP, among others.
Read More

Eiko Lifesciences Ltd (540204.BO) Chart

Key Statistics of Eiko Lifesciences Ltd (540204.BO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹49.00₹51.40

Today's Open

₹51.40

Volume

6011.00

P/E Ratio (TTM)

33.83

52 Week Range

₹45.90₹65.90

Market Cap

733.05M

Avg. Volume

10.91K

Dividend Yield

-

Financial Metrics & Statements of Eiko Lifesciences Ltd (540204.BO)

FAQ's for Eiko Lifesciences Ltd (540204.BO)

  • According to Musaffa’s Shariah screening methodology, Eiko Lifesciences Ltd (540204.BO) is currently classified as HALAL as of January 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.